Suzanne M. Fields
Concord Repatriation General Hospital(AU)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Cancer therapeutics and mechanisms, Neutropenia and Cancer Infections, Multiple Myeloma Research and Treatments, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation.(1995)152 cited
- → Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion.(1993)135 cited
- → Incidence and duration of chemotherapy-induced nausea and vomiting in the outpatient oncology population.(1989)96 cited
- → Topoisomerase I Inhibitors: An Overview of the Camptothecin Analogs(1994)58 cited
- → Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812)(1994)50 cited
- → A phase I clinical and pharmacokinetic study of the angiogenesis inhibitor, tecogalan sodium(1996)43 cited
- → A Phase II Trial of DaunoXome, Liposome- Encapsulated Daunorubicin, in Patients with Metastatic Adenocarcinoma of the Colon(1994)38 cited
- → Preclinical and phase I trials of topoisomerase I inhibitors(1994)33 cited
- Summary of data from in vitro and phase I vinorelbine (Navelbine) studies.(1994)
- → Idarubicin: A Second-Generation Anthracycline(1991)24 cited